Health care stocks fell Tuesday afternoon with the NYSE Health Care Index shedding 0.5% and the Health Care Select Sector SPDR Fund (XLV) down 0.4%.
The iShares Biotechnology ETF (IBB) was little changed, erasing earlier gains.
In corporate news, Surgery Partners (SGRY) shares jumped 18%. Bain Capital Partners delivered a non-binding proposal late Monday to Surgery Partners' board proposing to buy the remaining shares for $25.75 apiece in cash.
Silexion Therapeutics (SLXN) shares surged 79% after the company reported "promising" preclinical data from its tumor drug candidate, SIL-204, in mice.
Trinity Biotech (TRIB) shares jumped 53% after the company said the latest pre-pivotal trial for its continuous glucose monitoring technology yielded "breakthrough" results.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。